We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALZN icon
12476
PUT
Alzamend Neuro
ALZN
$7.43M
$10K ﹤0.01%
8
-19
-70% -$24.6K
LPCN icon
12477
PUT
Lipocine
LPCN
$17.4M
$10K ﹤0.01%
712
-1,759
-71% -$27.4K
PTIX
12478
DELISTED
Performance Technologies
PTIX
$10K ﹤0.01%
+258
New +$11.5K
SCLXW icon
12479
Scilex Holding Co Warrant
SCLXW
$10K ﹤0.01%
69,595
-4,316
-6% -$1.12K
SOUNW icon
12480
SoundHound AI Warrant
SOUNW
$658M
$10K ﹤0.01%
37,570
+70
+0.2% +$40
SY
12481
PUT
So-Young International
SY
$225M
$10K ﹤0.01%
11,300
-800
-7% -$1K
UAMY icon
12482
PUT
United States Antimony
UAMY
$825M
$10K ﹤0.01%
23,700
-5,300
-18% -$2.3K
DVLT
12483
Datavault AI
DVLT
$272M
$10K ﹤0.01%
1
-4
-80% -$52.5K
VCXB.WS
12484
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
$10K ﹤0.01%
101,134
-274,320
-73% -$46.7K
TTOO
12485
PUT
DELISTED
T2 Biosystems, Inc
TTOO
$10K ﹤0.01%
12
-2
-14% -$2.96K
PMGMW
12486
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$10K ﹤0.01%
126,538
EACPW
12487
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$10K ﹤0.01%
92,490
-200,796
-68% -$29.8K
SIEN
12488
CALL
DELISTED
Sientra, Inc.
SIEN
$10K ﹤0.01%
1,150
-280
-20% -$3.81K
ACOR
12489
CALL
DELISTED
Acorda Therapeutics
ACOR
$10K ﹤0.01%
1,020
+260
+34% +$4.62K
SEAC
12490
DELISTED
Seachange International Inc
SEAC
$10K ﹤0.01%
843
-2,885
-77% -$50.2K
FOXO.WS
12491
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
$10K ﹤0.01%
46,234
-356,607
-89% -$90K
PEARW
12492
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$10K ﹤0.01%
75,514
-464
-0.6% -$229
JCICW
12493
DELISTED
Jack Creek Investment Corp. Warrants
JCICW
$10K ﹤0.01%
129,260
-200,200
-61% -$30.1K
TZPSW
12494
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$10K ﹤0.01%
119,465
-165,595
-58% -$30.6K
JOFFW
12495
DELISTED
JOFF Fintech Acquisition Corp. Warrant
JOFFW
$10K ﹤0.01%
94,844
-245
-0.3% -$42
OEPWW
12496
DELISTED
One Equity Partners Open Water I Corp. Warrant
OEPWW
$10K ﹤0.01%
82,349
-356,467
-81% -$75.4K
MDH.WS
12497
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$10K ﹤0.01%
121,042
-394,476
-77% -$44.1K
TLGA.WS
12498
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$10K ﹤0.01%
125,567
-316
-0.3% -$46
AUTO
12499
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$10K ﹤0.01%
24,713
+12,259
+98% +$18K
AKBA icon
12500
PUT
Akebia Therapeutics
AKBA
$242M
$9K ﹤0.01%
26,100
-132,700
-84% -$55.7K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.